EUVIMEDScopri EUVIMED
Open access

Synaptic Deficits in Adnp‐ Mutant Mice Are Ameliorated by Histone Demethylase LSD1 Inhibition

Chih-Hung Lin, Yong Ren, Kin Wai Tam, Megan Conrow-Graham iD, Zhen Yan iD

Autism Research · 2025

DOI: 10.1002/aur.70069 ↗

At a glance

Journal article in Autism Research, 2025. Written by Chih-Hung Lin and 4 co-authors. Institution: Department of Physiology and Biophysics, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New Yor…. Major MEDLINE topics: Histone Demethylases, Synaptic Transmission, Nerve Tissue Proteins, Synapses. Cited 10 times so far (Crossref); 57 references. The full text is freely available in PubMed Central. Funded by: NIMH NIH HHS, NINDS NIH HHS, NIH HHS.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

ADNP (Activity‐dependent neuroprotective protein) is a top‐ranking autism risk gene. Here we examined synaptic alterations in heterozygous mice carrying an autism mutation on Adnp C‐terminus ( Adnp mut ). We found that PFC pyramidal neurons in Adnp mut mice exhibited significantly diminished glutamatergic and GABAergic synaptic transmission, as indicated by markedly reduced excitatory postsynaptic currents (EPSC) and inhibitory postsynaptic currents (IPSC). Given the key role of ADNP in chromatin regulation and the constitutive association of the ADNP complex with lysine‐specific demethylase 1 (LSD1), we examined the therapeutic effects of LSD1 inhibition in Adnp mut mice. We found that treatment with an LSD1 inhibitor significantly elevated EPSC and IPSC in PFC pyramidal neurons of Adnp mut mice, and the rescuing effect was particularly prominent in females. Biochemical assays revealed increased H3K4me2 and decreased H3K9me2/3 by LSD1 inhibitor treatment in female Adnp mut mice, which were correlated with the elevated expression of synaptic genes linked to glutamatergic and GABAergic transmission after the treatment. These data have revealed synaptic deficits in PFC induced by a loss‐of‐function mutation of Adnp and uncovered the therapeutic potential of LSD1 inhibition in ADNP‐deficient conditions, especially for females.

Subjects

MeSH terms (MEDLINE)

Histone DemethylasesSynaptic TransmissionNerve Tissue ProteinsSynapsesAutistic DisorderAnimalsMiceFemaleMalePyramidal CellsExcitatory Postsynaptic PotentialsDisease Models, AnimalPrefrontal CortexMutationInhibitory Postsynaptic Potentials

Substances

Histone DemethylasesKDM1a protein, mouseNerve Tissue Proteins

Authors and institutions

  • Department of Physiology and Biophysics, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York, USA.

ORCID profiles: Megan Conrow-Graham, Zhen Yan

Funding

  • NIMH NIH HHS
  • NINDS NIH HHS
  • NIH HHS
  • National Institutes of Health

Cite

APA

Lin, C. H., Ren, Y., Tam, K. W., Conrow-Graham, M., & Yan, Z. (2025). Synaptic Deficits in Adnp‐ Mutant Mice Are Ameliorated by Histone Demethylase LSD1 Inhibition. Autism Research. https://doi.org/10.1002/aur.70069

Vancouver

Lin CH, Ren Y, Tam KW, Conrow-Graham M, Yan Z. Synaptic Deficits in Adnp‐ Mutant Mice Are Ameliorated by Histone Demethylase LSD1 Inhibition. Autism Research. 2025. doi:10.1002/aur.70069

BibTeX
@article{Lin2025,
  author = {Lin, Chih-Hung and Ren, Yong and Tam, Kin Wai and Conrow-Graham, Megan and Yan, Zhen},
  title = {Synaptic Deficits in Adnp‐ Mutant Mice Are Ameliorated by Histone Demethylase LSD1 Inhibition},
  journal = {Autism Research},
  year = {2025},
  doi = {10.1002/aur.70069}
}
Start for free →